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Our conditional serum response factor (SRF) knockout, SrfCko, in
the heart-forming region blocked the appearance of rhythmic
beating myocytes, one of the earliest cardiac defects caused by the
ablation of a cardiac-enriched transcription factor. The appearance
of Hand1 and Smyd1, transcription and chromatin remodeling
factors; Acta1, Acta2, Myl3, and Myom1, myofibril proteins; and
calcium-activated potassium-channel gene activity (KCNMB1), the
channel protein, were powerfully attenuated in the SrfCKO mutant
hearts. A requisite role for combinatorial cofactor interactionswith
SRF, as a major determinant for regulating the appearance of
organized sarcomeres, was shown by viral rescue of SRF-null ES
cells with SRF point mutants that block cofactor interactions. In the
absence of SRF genes associated with biomineralization, GATA-6,
bonemorphogenetic protein 4 (BMP4), and periostinwere strongly
up-regulated, coinciding with the down regulation of many SRF
dependent microRNA, including miR1, which exerted robust si-
lencer activity over the induction of GATA-6 leading to the down
regulation of BMP4 and periostin.
heart development  microRNA  periostin  cardiogenesis  GATA6
The heart is the first organ to form in mammals, controlled by anexquisite program that results in the assembly of organized
sarcomeres that rhythmically beat. First, molecular principles un-
derlying sarcomerogenesis were based on the gene-switch paradigm
in which nonmuscle actins are replaced by smooth muscle and
cardiac -actins in the heart-forming region (1, 2). Serum response
factor (SRF), identified by Treisman and colleagues (3), and a
MADS (MCM1, Agamous, Deficiens, serum response factor) box
transcription factor may play a critical role in sarcomerogenesis, as
deduced from transfection assays demonstrating the essential role
of SRF binding sites, or CArG boxes, for switching on cardiac gene
transcription, competition with negative acting YY1 andHOP, and
cardiac restricted expression (reviewed in ref. 4). Cardiac progen-
itors receiving the appropriate developmental cues switch on
several cardiac-restricted transcription factors such as Nkx2–5,
GATA-4, and myocardin that interact with SRF to activate many
cardiac and smooth-muscle structural genes (reviewed in refs. 4, 5).
SRF target genes are also involved with contractility, cell move-
ment, and cell growth signaling (6, 7) and the recently discovered
microRNAs, required for normal heart development (8).
The function of SRF in heart development in vivo has been
obscured by the early lethality of SRF null mice before the onset of
cardiogenesis (9). Even recent SRF inactivation studies in the heart,
performed through a conditional knockout strategy by using Cre
recombinase driven by late expressing transgenic promoters such
as, SM22, and or / myosin-heavy chains, failed to reveal an
obligatory role for SRF in controlling the appearance of beating
myocytes (10–12). That failure is because SRF induced during early
cardiogenesis is relatively stable and sarcomeres appeared even
after Cre recombinase mediated ablation of the SRF genetic locus
(12). To dissect out SRF’s role during early cardiac myocyte
commitment and differentiation, we generated lineage-specific
deletion of SRF with our Nkx2.5Cre (13) and SrfLoxP/Loxp mice (14)
in the HFR, well before SRF protein actually accumulated in the
heart.
Results
The SRF Cardiac-Null Mutant Exhibited Nonbeating and Heart-Looping
Defect. To block the appearance of SRF before the appearance
of beating cardiac myocytes, we engineered a mouse that
carried both Srf LacZ and Nkx2.5Cre on chromosome 17 which
was then bred to SRFLox/Lox mice to generate a conditional
SRF knockout (SrfCko) in the heart-forming region. The SrfCko
mutant genotyped as Srf LacZ/Flox:Nkx2.5Cre was first discern-
ible at approximately 8.0 dpc (linear heart-tube stage) with a
nonbeating heart tube (Fig. 1A). Immunof luorescence staining
with anti-SRF antibodies showed SRF staining in myocytes of
haploid SRF mutant embryos and the absence of SRF in the
SrfCko embryo (Fig. 1 B–E). This tubular structure misplaced
the anterior portion of the developing out-f low tract in the
SrfCkomutant (Fig. 1 F andG). By8.5 dpc, severe ventricular
dilation and cranially retained right ventricle/outf low tract
were 2 common morphological defects of this motionless
tubular heart (Fig. 1 H and I) The outf low tract derived from
second heart field (SHF) was undersized, as shown by Wnt11
expression (Fig. 1 J and K, ref. 15), whereas cardiac field-
marker genes Nkx2.5 (16) and Fgf10 (17) appeared unaffected
(Fig. 1 L–O).
SRF Guides Cardiac Myogenesis. Smooth muscle and cardiac -actin
gene RNA transcripts emerging at the late cardiac-crescent stage
(7.75–8.0 dpc) were blocked in SrfCko mutant hearts (Fig. 2 A–H).
Immunofluorescence staining confirmed the absence of smooth
muscle and striated -actin in the hearts of SrfCko embryos (Fig. 2
C,D,G, andH). Expression ofMyl2 andMyom1 components of the
thick filament and M-band of sarcomeres were dependent on SRF
expression (Fig. 2 I–L). Analysis with transmission electronmicros-
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copy indicated that neither aligned filaments nor Z disks that were
formed in multiple SrfCko cardiac mutants correlated well with the
nonbeating heart (Fig. 2 M–Q). These ‘‘paralyzed’’ mutant hearts
did not display any sarcomere signatures in multiple SrfCko mutant
samples.
The appearance of Smyd1, a cardiac and skeletal muscle-
specific chromatin-remodeling factor (18) failed to appear in
the nascent SrfCko mutant myocytes (Fig. 3 A and B). Expres-
sion of Tgf1/1, a LIM protein that serves as a cofactor with the
androgen receptor and p300 (19), was also blocked in the
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Fig. 1. Early cardiac restricted Srf knockout exhib-
ited nonbeating and cardiac looping defects. (A)
Quantitative summary of the number of beating
hearts observed for control and Srf Cko embryos at
8.25 dpc. (B–E) Immunofluorescent staining of con-
trol Srf Lox/ and Srf Cko embryo sections anti-SRF
(green) antibodies. Boxed areas in B and C were
magnified in panels D and E. (F–I) Control (ctr)
Srf Lox/ and Srf Cko embryos at 8.25 dpc. Cardiac
looping was affected in Srf cko embryo. Red dashed
line, body middle line. Whole mount lacZ staining
revealed the right ventricle and outflow tract (arrow
head) and the dilated left ventricle (open arrow) in
Srf Cko embryo. (J and K) Reduced Wnt11 RNA tran-
scripts in the Srf Cko embryo indicated an undersized
outflow tract and a SHF at 7.75 dpc. (L–O) The first
heart field appeared unaffected, as shown by the
similar levels of Nkx2.5 and Fgf10 RNA transcripts in
both the control and Srf Cko embryo at 7.75 dpc.
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Fig. 2. SRF insufficiency shuts down cardiac myocyte
differentiation. (A–H) Whole mount in situ hybridiza-
tion and immunofluorescence staining showed the ab-
sence ofActa2 (smoothmuscle -actin) andActc1 (car-
diac -actin) expression in the Srf Cko embryo in
comparison to control embryos at 8.5 dpc. (I–L) Whole
mount in situ hybridization showed down-regulation
ofMyl2 andMyom1 in Srf Cko embryos. (M–P) Transmis-
sion EM revealed organized sarcomere structure in
control (M andO) but not Srf Cko sections (N and P). (Q)
Quantitative summary of contractile structures recog-
nized inmultiple control and Srf Cko samples. In control
samples (M and O) Z-lines were observed at high inci-
dence (n 10:21 myocytes), whereas aligned filament
bundles were observed in all control samples. ‘‘Disar-
rayed’’ filament structures shown within the dotted
lines were observed in less than half of the Srf cko
mutant cells (n  11:27 cells) which shared a diameter
at 10 nm, same as noncontractile intermediated fila-
ments (N and P).
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SrfCko mutant heart (Fig. 3 C and D). Expression of the Hand1
gene, a first heart-field maker, was reduced in the SrfCko
mutant (Fig. 3 E and F), and may have also contributed to
ventricular dilation. Appearance of calcium-activated potas-
sium-channel gene activity (KCNMB1) was blunted in the
SrfCko mutant hearts (Fig. 3 G and H). Many of these genes
were validated for the presence of conserved CArG elements
in their promoters (Fig. 3I).
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Fig. 4. Rescue of cardiac myogenic differentiation defect in Srf -null ES cells by SRF wild-type and interaction defective mutants reveal an obligatory role for
SRF and cofactor interactions to drive sarcomerogenesis and contractility. (A) SRF contains an evolutionary conserved MADS box domain that allows for
dimerization of SRF monomers and DNA binding to a CArG element. This diagram shows the N-extension, alpha I coil, beta I sheet, beta-loop, beta II sheet, and
alpha II coil of the SRF-DNA crystal structure adapted from Pellegrini et al. (37). Alanine substitution mutations were made in the MADS box at amino acids
145–147 (SRF-145) and at amino acids 194 and 196 (SRF-194). (B) Affymetrix expression microarray showed a subset of genes that were consistently affected by
the lentiviral rescue of SRF-null ES cells with wild-type SRF during embryoid body formation leading to cardiac cell differentiation. (C) Quantitative RT-PCR
showing the effects of the rescue of Srf-null ES cells with lentiviruses expressing SRF wild-type and SRF point mutants on the expression of SRF targets, which
includedActa2,Actc1,Myh6,Hand1, Smyd1, and cardiac regulatory factorsNkx2.5 andGata4. (D) Immunofluorescent detection of sarcomeric -actin following
lentivirus mediated infection and expression of SRF and point mutants SRF-145 and SRF-194 in Srf/ ES cell. (E) Beating embryoid bodies were found only in
Srf-null ES cells rescued by lentiviral infection with SRF wild type.
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Fig. 3. Identification of novel SRF down-
stream target genes important for sarcom-
erogenesis and electrical coupling. (A and B)
Whole mount in situ hybridization of Smyd1,
(C and D) Tgf1/1, (E and F) Hand 1, (G and H)
KCNMB1 showed reducedexpressionof these
genes in Srf Cko embryos in comparison to con-
trol Srf/lox embryos at8.5 dpc. (I) RNA sam-
ples isolated from control and SRFCko mutant
embryonic heartswerehybridizedagainstAf-
fymetrix array 430a2 chip. Microarray raw
data analysis was done with dCHIP software
(www.dchip.org). Note the down-regulation
of SRF gene targets. Genome TraFac searched
putative SRF binding motifs 5 kb upstream to
the1st exon, andmotifs displayingabove70%
similarity between human and murine ge-
nome were noted by asterisks.
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SRFMutants Block Sarcomerogenesis in Srf-null ES Cells.The idea that
SRF activity is largely controlled by its interaction with cofactors
was tested by a ‘‘gain-of-function’’ approach applied to Srf-null ES
cells. We focused on two mutants: SRF-145 (triple alanine substi-
tutions 145–147 amino acids) and SRF-194 (dual alanine substitu-
tions at 194 and 196 amino acids; Fig. 4A. These two mutants did
not interfere with DNA binding, but prevented their coassociation
and facilitated binding of SRF with Nkx2.5/GATA4 (SRF-145
mutant), or myocardin [SRF-194 mutant; supporting information
(SI) Fig. S1]. Increased expression of wild-type SRF and mutants
by the lentivirus system was sufficient to either rescue completely
and or in part the cardiac myogenesis defect of Srf/ ES cells (Fig.
4 B–D). Microarray analysis and quantitative RT-PCR confirmed
the rescue and enhanced expression of Hand1 and Smyd1, tran-
scription and chromatin remodeling factors, Acta1, Acta2, Myl3,
andMyom1, myofibril proteins, andKcnmb1 excitation contraction
coupling proteins by SRF replenishment in Srf/ ES cells (Fig. 4
B and C). Measurement of GATA4, myocardin, and MRTFs
transcripts indicated that there were sufficient amounts of these
factors to allow for gene activation in the presence of the SRF
mutants (Fig. S2). Moderate elevation of some structural gene
expression was elicited by either SRF-145 or SRF-194, but neither
mutant alone was sufficient to drive terminal cardiac myocyte
differentiation, as determined by immunofluorescent staining of
organized sarcomeres, microarray analysis, and beating cardiac
myocytes (Fig. 4 D and E, and Movies S1–S4). Given the fact that
SRF directed the appearance of beating myocytes from SRF-null
ES cells, we conclude that the inability of the SRF interaction-
defective mutants to rescue myogeneis highlighted the significance
of these cofactor associations in cardiac myogenesis and not their
absence.
SRF, a Biomineral and Extracellular Gene Program Silencer. Analysis
of cardiac SrfCko also revealed strong up-regulation of GATA-6,
bonemorphogenetic protein 4 (BMP4), and periostin (Postn) genes
associatedwith biomineral formation (Fig. 5A), in the regions of the
endocardium destined to become the septum and outflow tract and
the SHF (Fig. 5 B–G). Postn is expressed in the mesenchymal-
derived cardiac fibroblasts, valvular attachment apparatus, and
epicardial/pericardial structures, but is absent from the cardiomy-
ocyte lineage (20). Expression of BMPs in the myocardium is
critical for the induction of Postn (21). mef2c-AHF-Cre transgenic
mice were used to direct the expression of Cre recombinase
exclusively in the anterior heart field and its derivatives to condi-
tionally ablate the Bmp4Lox/Lox gene. Endothelial and myocardial
components of the outflow tract, right ventricle, and ventricular
septumwere shown to be derivatives of mef2c-AHF-Cre expressing
cells (22). The mef2c-AHF-Cre transgene-induced knockout of
Bmp4Lox/Lox in the E10.5 mouse embryonic-mouse heart blocked
the appearance of Postn in the outflow tract (Fig. 5 H and I). In
addition, closely related BMP-2 induced periostin expression in
cardiac-cushion mesenchymal cells (21), thus support the role of
BMP signaling, leading to periostin expression.
Periostin may also suppress myocyte differentiation. Conversely,
periostin deletion might result in enhanced and/or ectopic myocyte
differentiation. To distinguish the appearance of cardiomyocytes
from the Postn-expressing noncontractile tissues, we made use of
theMHC-EGFP reportermice (23) that express EGFP exclusively
in cardiac muscle in the background of targeted-null (PostnLacZ)
neonatal mice. Surviving adult PostnLacZ-null hearts contained
ectopic MHCEGFP expression, as EGFP-positive islands in the null
epicardium (n  9:13 PostnLacZ null MHCEGFP hearts examined;
Fig. 5J). This was confirmed via costaining with the myocardial-
marker MF20 in PostnLacZ null, but not wild-type, epicardium (not
shown).
SRF Directs the Expression of Many MicroRNAs Including miR1. SRF
may exert gene silencing activities through its regulation over
microRNAs (miRNAs). In day 9.5 SrfCko embryonic-mutant hearts,
20 miRNAs, each of which contain at least 1 conserved CArG
element in their promoters, were down-regulated in comparison to
control heart samples (Fig. 6A). Among these miRNAs, miR-1 (8)
was shown to be controlled by SRF through its 3 CArG boxes (24).
In addition, mice lacking miR-1–2 have a spectrum of cardiac
abnormalities also allowed for the induction of GATA-6 (8).
Greater than 90% of miR-1 RNA transcripts were blocked in the
SrfCko hearts, whereasGATA6mRNA levels increased over 18 fold
(Fig. 6 B and C). Thus, tissue-specific expression of miRNAs
regulated by SRF at the transcriptional level may have a strong
regulatory activity over the noncontractile endocardial/epicardial
gene activity.
miR-1 Blocked GATA6 and Periostin Expression. To test this idea, we
evaluated the role of SRF in regulation of miR-1 in the SRF
lentiviral rescue of Srf-null ES cells (Fig. 6). Viral-expressed
SRF induced about a 30-fold increase in miR-1 RNA, as shown
by quantitative RT PCR analysis (Fig. 6D). We observed
increased levels of GATA6 (BMP2:4; data not shown) and
periostin in Srf-null ES cells, and stable transfectants of these
ES cells with miR-1 significantly repressed GATA6 and Postn
expression, whereas miR-133, the miR-1 bicistronic partner,
failed to inhibit their expression (Fig. 6 E and F). Of the key
biomineralization genes, only the well-conserved sites in
mouse and rat GATA6 3UTR, are favorably accessible,
according to the algorithm reported by Zhao et al. (8; (Fig. S3).
MiR-1 sites were not detected in Postn; thus, miR1 indirectly
inf luenced Postn expression most likely through the silencing
of GATA6.
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Fig. 5. Activation of biomineralization markers observed in SrfCko mutant
hearts. (A) dCHIP analysis of prominent genes up-regulated in the SrfCko embryo.
Wholemount in situhybridizationof (BandC) Gata6, (DandE) BMP4, and (Fand
G) Postn showed elevated expression of these genes in SrfCko embryos in com-
parison to control Srf Lox/ embryos at approximately 8.5 dpc. (H and I). Whole
mount in situ hybridization showed inducedexpressionof Postn in theBmp4Cko
heart in comparison to the control Bmp4Lox/:Mef2CCre heart. (J) Ectopic appear-
ance of cardiacmyocytes (white arrowhead, tg--MHC-eGFP positive) identified
in epicardium layer of the Postn-null heart.
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Discussion
SRF Orchestrates Cardiac Myogenesis Through Multiple Levels of
Regulation. Our study provides inconvertible evidence that SRF
activity controls sarcomerogenesis in higher vertebrates, as mod-
eled in the schematic diagram in Fig. 6G. Recently, Fukushige et al.,
(25) demonstrated that UNC-120, theC. elegans equivalent of SRF,
was required to initiate a body-wall muscle program in naive early
blastomeres and to drive muscle-structural gene activity. The
unc-120-null mutants exhibited low-level myofilament protein pro-
duction. The ability for SRF to be the universal ‘‘myogenic driver’’
was totally abrogated in the Srf-null cells and supports the concept
that SRF resides at a high point in the regulatory hierarchy
governing sarcomerogenesis from worms to mammals. Addition-
ally, SRF activity was also controlled to a large extent through
combinatorial factor interactions with tissue-specific regulatory
cofactors and was supported by our rescue of Srf null ES cells with
lentiviral-expressed SRF-point mutants that blocked co-factor as-
sociation, but not DNA binding activity. Because SRF mutants
were incapable of restoring sarcomerogenesis, our data supports
the claim that SRF plays an obligatory role in cardiac myogenesis
with a requirement for SRF cofactor interactions.
In the absence of Srf, we observed the strong up-regulation of
biomineral and extracellular matrix-gene activity. GATA6 contrib-
utes to septal and valvular development via its direct transcription
target, BMP4, leading the induction of Postn (26). The deletion of
the BMP type 1A receptor in the endocardium also resulted in
failed cushion formation, indicating that BMP signals directly to
cushion-forming endocardium to induce epithelial-mesenchyme
transition (27). Transformation of atrioventricular (AV) canal
endocardium into invasive mesenchyme correlates spatially and
temporally with the expression of BMPs in the atrioventricular
myocardium crucial for the induction of Postn (28). Ku¨hn et al. (29)
showed that periostin-induced cardiomyocyte cell-cycle reentry and
mitosis, whereas periostin expression was associated with improved
ventricular remodeling and myocardial function (30). We showed
that conditional abrogation of periostin by targeted gene-deletion-
activated cardiac-cell differentiation, as exemplified by the ectopic
expression of the MHCEGFP-fluorescent gene reporter (Fig. 5).
SRF, a Powerful Silencer Directs the Expression of Many miRNAs,
Including miR-1. SRF may also direct the expression of many miRs
that inhibit the expression of cardiac regulatory factors that influ-
ence cardiac lineage specification. Twenty miRs were significantly
down-regulated in the SRFCko-mutant heart (Fig. 5A). As shown
here,miR-1RNA transcripts were dependent uponSRFexpression
and were blocked in SrfCko hearts. Rescue of SRF-null ES cells with
viral expressed SRF induced thirty-fold increase in miR-1 RNA
(Fig. 6). Increased levels of GATA6 and Postn in Srf-null ES cells
were also attenuated by miR-1, but not by miR-133, the miR-1
bicistronic partner. Thus, miR-1 appears to play an important role
in regulating GATA6 expression leading to endocardial/epicardial
gene silencing. In addition, Chen et al. (31) showed that expression
of miR-133 repressed myoblast differentiation by repressing SRF
expression. Thus, miR-133 is controlled by SRF, yet directs a
negative regulatory loop through inhibiting SRF translation (Fig.
6G). Possibly, the delicate balance of SRF-directed silencing of
miRNA activity may be even more profound in human heart
disease. Chang et al. (32) found SRF was cleaved by caspase 3 in
human heart failure and generated its dominant-negative SRF-N in
the failing human myocardium. Thus, during the onset of heart
failure, cleaved SRF will likely interfere with SRF’s global role in
controlling genes required for sarcomerogenesis, but may also
hinder the expression of SRF-dependentmiRNAs that silence gene
activities causing dysregulation of normal cardiac performance.
Experimental Procedures
Generation of SRF Cardiac Progenitor-Conditional Null Embryos and Transient
Transgenics. The SRF LacZ ‘‘knock-in’’ mouse SRF LacZ/ (33) and the Cre-
conditional SRFLoxP/LoxP mouse (13) were previously generated. Cardiac progen-
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Fig. 6. Regulation of SRF-dependent microRNA
and miR-1 targets. (A) Microarray analysis of SRF-
dependent microRNAs that were down-regulated in
the srf cko-mutant hearts. Genome-wide microRNA
expression profiling was accomplished with RNA
samples taken from control and SRFCKO-mutant
hearts and hybridized on a mouse microRNA mi-
croarray platform (MRA-1002, LC Sciences) con-
tained 568 unique mature miRNA sequences. (B)
Quantitative RT-PCR showed down-regulation of
miR-1 (including miR-1–1 and miR-1–2) in RNA taken
from SRFCKO-mutant hearts in comparison to control
samples. (C) Quantitative RT-PCR showed up-
regulation of Gata6 in Srf cko-embryo heart samples.
(D). Quantitative RT-PCR showed rescue of Srf/ ES
cells with lentviral expression of SRF, as shown in Fig.
4, strongly induced miR-1 RNA transcripts. (E and F)
Quantitative RT-PCR showed that stable transfec-
tants of miR-1, but not miR-133, its bicistronic part-
ner, in Srf/ ES cells blocked the expression of
GATA6 and periostin. (G) Schematic diagram shows
the role of SRF and cofactors in regulating sarco-
meric downstream targets that includes coding and
noncoding microRNA. SRF cofactors facilitate SRF
binding to promoters that drive the expression of
heart restricted transcription factors, sarcomeric
contractile proteins, ion channels, and the 20 miR-
NAs which were shown as downstream targets of
SRF. This diagram also summarizes the roles of the
SRF dependent miR1 silencing of the GATA6, BMP4,
and periostin dependent biomineralization and con-
nective tissue expression gene activity and miR133
inhibiting SRF expression.
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itor-specific Cre-recombinase transgenic mice (Nkx2.5Cre) were used to mediate
committed cardiac cell Cre/LoxP recombination (12). All mice used in this study
were crossed into theC57/B6background. Becauseboth Srf andNkx2.5 resideon
the same chromosome in murine genome at 17B3 and 17A3.3, respectively, we
first selected a chromosome carrying both Srf LacZ and Nkx2.5Cre. This double
positive allele, Srf LacZ:Nkx2.5Cre, was then bred with Srf Lox/ or Srf Lox/Lox (14) to
generate an early cardiac specific Srf knockout. Genotyping was performed by
PCRanalysisof tailDNAforadultmiceandyolk-sacDNAforembryosaspreviously
described (4, 12, 13). Periostin (34) andBMP4 (35) knockoutmicewere previously
described. PostnLacZ mice were intercrossed with MHCEGFP-reporter mice (23).
The mef2c-AHF-Cre-transgenic mice (22), a generous gift from Dr. Brian Black
(University of California, San Francisco, CA),wereused todirect the expressionof
Cre recombinase exclusively in the anterior-heart field and its derivatives to
conditionally ablate the BMP4Lox/Lox gene.
Embryo Collection and RNA In Situ Hybridization. Embryos were collected and
used inwhole-mount in situ hybridization assays with digoxigenin (DIG)-labeled
cRNAprobes as described (11). Antisense probes forActa2,Actc1,Nkx2.5,Mylc2,
Gja5 (11), Wnt11, Handl and Gata6, Fgf10, BMP4, Periostin, Myom1, Smyd1,
Tgf1i1, and Kcnmb1 were generated in our laboratories. Detailed probe infor-
mation is available upon request. Sense probes showed no signal (data not
shown).
Immunohistochemistry and Transmission Electron Microscopy. Serial transverse
sections of staged embryos were treated with primary antibodies at 4 °C over-
night as described (11). Primary antibodies were anti-SRF (G20 and H300 from
Santa Cruz, 1:200), antisarcomeric actin (5C5 from Sigma, 1:100), anti-SM actin
(1A4 fromSigma, 1:200). Afterwashing, secondary antibodieswere incubated at
room temperature for 1 h. Fluorescent-tagged secondary antibodies were ap-
pliedat1:200dilutions (MolecularProbes). ImagesweredocumentedwithaZeiss
LSM 510 laser confocal microscope. Control and SrfCko mutants were fixed in
2.5% glutaraldehyde and 2.0% formaldehyde and sequentially embedded in
resin. Sagittal sections spaced 5 m apart were collected. Images were taken
under a Hitachi H-7500 transmission electron microscope. Twomyocytes spaced
by 3 cells on each section were scanned for morphometric analysis.
Embryonic Stem Cell Culture and Lentiviral Rescue. Both AB2.2 and Srf/ ES cell
weremaintainedatoptimal conditionwith lymphocyte inhibitory factor. Embry-
oidbody (EB)differentiationwaspreviouslydescribed (11). EBswere collectedon
day 4.5 and plated onto 0.1% gelatin-coated dishes. Beating myocytes were
normally observed 7–8 days postplating. pWPI vector was a generous gift from
Dr.D. Trono (EcolePolytechniqueFe´de´raledeLausanne, Lausanne, Switzerland).
HumanSRFcDNAandmutantswithN-terminalHAtagwereclonedintotheEcoRI
site. Lentiviruses for miRNA expression were generated as described (36). For
transduction, freshly trypsin-dissociated ES cells were mixed with lentivirus at a
multiplicity of infection of 100, by using 8 g/ml polybrene (Sigma). Three days
later, the upper 50% of EGFP cells were isolated (Beckman–Coulter Altra) and
subjected to EB culture as above.
Microarray and Quantitative Real-Time PCR. Control and Srf cko hearts were
dissectedfreeof theembryosat8.5dayspostcoitum(dpc) (6–9somites),pooled
(30 hearts) for RNA isolation with TRI reagent (Sigma), and treated with RNase-
free DNaseI (Roche) to remove genomic DNA. RNA was transcribed by using
M-MLV reverse transcriptase (Promega). PCR amplification was performed by
usingTaqpolymerase (TaKaRa). For SRF lentivirus rescuesof SRFnull ES cells, RNA
was isolated 10 days after forming and plating embryoid bodies. RNA samples
were hybridized against Affymetrix array 430a2 chips. Microarray raw data
analysis was done with dCHIP software (www.dchip.org). Quantitative RT-PCR
analysis for GAPDH, Hand1, Smyd1, has-miR-1, and periostin (probes purchased
from Applied Biosystems Inc.) and Gata6, cardiac -actin (Actc), smooth muscle
-actin (Acta2), Nkx2.5, andGata4 (generatedbyNiu et al., 2005)was performed
with Taqman probes in an Applied Biosystems Prism 7700. GAPDH served as a
loading control. Wild-type controls were given a value of 1.0. Genome-wide
microRNA expression profiling was accomplished with RNA samples taken from
control andSRFCKO-mutanthearts andhybridizedonamousemicroRNAmicroar-
ray platform (MRA-1002, LC Sciences) that contained 568 uniquematuremiRNA
sequences. Selected probes with expression scores 200 were significantly af-
fectedinSRFCkoheart (t test,P0.01 in6probesets).ConservedSRFbindingmotif
searches were performed with TraFac (http://trafac.cchmc.org).
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